Literature DB >> 2311750

Mind-body problems in family therapy: contrasting first- and second-order cybernetics approaches.

J L Griffith1, M E Griffith, L S Slovik.   

Abstract

Using detailed case examples, we contrast first- and second-order cybernetics approaches to family problems involving somatic symptoms in a family member. A second-order cybernetics approach views the reality of the problem as linguistically shaped by those interacting around it, including the therapist and observing team members. This co-constructed reality, the story of the problem, inadvertently contributes to the problem's endurance by narrowing the choice of more effective solutions. In our approach, the therapist elicits from each person his or her story about the illness in the family. The therapist then facilitates a therapeutic conversation that provides a context for new linguistic distinctions to be drawn, including the way mind and body may interact to generate the symptoms. Shifts in beliefs and behaviors follow, and more innovative solutions to the problem can then emerge. Unlike the approach in our previously published work based upon ecosystemic patterns as "system diagnoses," this approach uses only descriptions and explanations of the problem as are collaboratively constructed within this therapeutic conversation.

Entities:  

Mesh:

Year:  1990        PMID: 2311750     DOI: 10.1111/j.1545-5300.1990.00013.x

Source DB:  PubMed          Journal:  Fam Process        ISSN: 0014-7370


  2 in total

1.  Family therapy education for psychiatry residents : a pilot study of efficacy.

Authors:  G L Schmidt; M J Bonjean
Journal:  Acad Psychiatry       Date:  1995-06

2.  Understanding How Parents Make Meaning of Their Child's Behaviors During Screening for Autism Spectrum Disorders: A Longitudinal Qualitative Investigation.

Authors:  Thomas I Mackie; Ana J Schaefer; Leah Ramella; Alice S Carter; Abbey Eisenhower; Manuel E Jimenez; Angel Fettig; R Christopher Sheldrick
Journal:  J Autism Dev Disord       Date:  2021-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.